| Cannabinoids: therapeutic use in clinical practice C Pagano, G Navarra, L Coppola, G Avilia, M Bifulco, C Laezza International journal of molecular sciences 23 (6), 3344, 2022 | 177 | 2022 |
| Cannabinoids in the modulation of oxidative signaling C Pagano, B Savarese, L Coppola, G Navarra, G Avilia, C Laezza, ... International Journal of Molecular Sciences 24 (3), 2513, 2023 | 25 | 2023 |
| N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells C Pagano, G Navarra, L Coppola, G Avilia, O Pastorino, R Della Monica, ... Cell death discovery 8 (1), 173, 2022 | 19 | 2022 |
| Impacts of environmental pollution on brain tumorigenesis C Pagano, G Navarra, L Coppola, B Savarese, G Avilia, A Giarra, ... International Journal of Molecular Sciences 24 (5), 5045, 2023 | 16 | 2023 |
| N6-isopentenyladenosine hinders the vasculogenic mimicry in human glioblastoma cells through Src-120 catenin pathway modulation and RhoA activity inhibition C Pagano, G Navarra, O Pastorino, G Avilia, L Coppola, R Della Monica, ... International Journal of Molecular Sciences 22 (19), 10530, 2021 | 10 | 2021 |
| Advances in “adiponcosis”: Insights in the inner mechanisms at the base of adipose and tumour tissues interplay C Pagano, E di Zazzo, G Avilia, B Savarese, G Navarra, MC Proto, D Fiore, ... International Journal of Cancer 152 (12), 2464-2473, 2023 | 7 | 2023 |
| N6-Isopentenyladenosine impairs mitochondrial metabolism through inhibition of EGFR translocation on mitochondria in glioblastoma cells C Pagano, L Coppola, G Navarra, G Avilia, S Bruzzaniti, E Piemonte, ... Cancers 14 (24), 6044, 2022 | 3 | 2022 |
| N6‐isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity C Pagano, L Coppola, G Navarra, G Avilia, B Savarese, G Torelli, ... FEBS Open bio 14 (5), 843-854, 2024 | | 2024 |
